Executive Profile

Srinivas Akkaraju M.D., Ph.D. General Partner , Sofinnova Ventures, Inc.

Age	Total Calculated Compensation	This person is connected to 4 Board Members in 4 different organizations across 15 different industries. See Board Relationships
44	--

Background

Dr. Srinivas Akkaraju, Sririni, MD, PhD. has been General Partner of Sofinnova Ventures, Inc. since May 2, 2013. Dr. Akkaraju actively invests in biopharmaceutical companies. He served as a Managing Director and Lead of West Coast Biopharmaceuticals Practice at New Leaf Venture Partners. Dr. Akkaraju joined New Leaf Venture Partners on January 22, 2009. He concentrated on biopharmaceuticals investments and has over 11 years of experience in life sciences investing and ... business development. He co-founded Panorama Capital and served as its Managing Director from 2006 to 2008. Dr. Akkaraju focused primarily on life sciences investments and was part of the Life Sciences Team. He joined J.P. Morgan Partners, LLC in April 2001 and served as a Partner in the life sciences team in the Healthcare Group, where he was responsible for leading venture investing in biotech companies. From October 1998 to April 2001, Dr. Akkaraju was in the Business and Corporate Development Group at Genentech, Inc. and served as its Senior Manager, where he was responsible for worldwide partnering activities including technology access deals, in-licensing of early and late-stage therapeutics, and out-licensing of Genentech development projects. He also served for the last year as the Project Team Leader for one of Genentech's clinical development products. During this time, Dr. Akkaraju was also a Founding Member at BioStreet. He serves as the Chairman of the Board of Principia Biopharma Inc. Dr. Akkaraju serves as a Director of Pharmos, Inc., Karus Therapeutics Limited, and Principia Biopharma Inc. He has been a Director of Intercept Pharmaceuticals, Inc. since September 2012 and Seattle Genetics Inc., since July 2003. Mr. Akkaraju served as a Director of Barrier Therapeutics Inc., since May 2002, Presidio Pharmaceuticals Inc. since August 29, 2007 and Phenomix Corporation since April 2005. He served as a Director of Synageva BioPharma Corp. from October 20, 2009 to June 27, 2012. Mr. Akkaraju served as a Director of Piramed Limited, Itero Biopharmaceuticals, LLC, Microscience Limited, Vela Pharmaceuticals, Inc., BioStreet.com, and Eyetech Pharmaceuticals, Inc. He served as Director of Versartis, Inc. He served as a Director of Oldtech, Inc. since July 2001, Amarin Corporation plc from May 23, 2008 to May 15, 2009 and Pharmos Corp. from October 2006 to March 29, 2011. He is the author of a number of peer-reviewed articles, including ones published in Science and Nature. Dr. Akkaraju holds a Ph.D. and an M.D. in Immunology from the Stanford University of Medicine and a B.A. in Biochemistry and Computer Science from Rice University in 1990.

Corporate Headquarters 7 Times Square New York, New York 10036 United States Phone: 646-871-6400 Fax: 646-871-6450 Board Members Memberships Former Director Vela Pharmaceuticals Inc. Former Director Piramed Limited Director Karus Therapeutics Limited Former Director Itero Biopharmaceuticals, LLC Former Director Versartis, Inc. Chairman Principia Biopharma Inc. 2001-N/A Former Director, Member of Audit Committee and Member of Compensation Committee Oldtech, Inc. 2002-N/A Former Director and Member of Corporate Governance & Nominating Committee Barrier Therapeutics, Inc. 2003-Present Director Seattle Genetics Inc. 2005-N/A Former Director and Member of Compensation Committee Phenomix Corporation 2006-2011 Former Independent Director and Member of Audit Committee Pharmos Corp. 2007-N/A Former Director Presidio Pharmaceuticals, Inc. 2008-2009 Former Non Executive Director Amarin Corporation plc 2009-2012 Former Director and Member of Audit Committee Synageva BioPharma Corp. 2012-Present Director and Member of Nominating & Governance Committee Intercept Pharmaceuticals, Inc. Education BA 1990 Rice University PhD Stanford University School of Medicine MD Stanford University School of Medicine Other Affiliations J.P. Morgan Partners, LLC Synageva BioPharma Corp. Genentech, Inc. Seattle Genetics Inc. Stanford University Pharmos Corp. Amarin Corporation plc BioStreet.com Vela Pharmaceuticals Inc. Rice University Oldtech, Inc. Phenomix Corporation Barrier Therapeutics, Inc. Piramed Limited Stanford University School of Medicine Intercept Pharmaceuticals, Inc. Karus Therapeutics Limited New Leaf Venture Partners Panorama Capital Presidio Pharmaceuticals, Inc. Itero Biopharmaceuticals, LLC Versartis, Inc. Principia Biopharma Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.